載入...
Long‐Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis
BACKGROUND. Metastatic pancreatic ductal adenocarcinoma (mPDAC) is an aggressive malignancy with a median overall survival (OS) of between 8 and 11 months. However, a significant number of patients experience a longer survival, more than 18 months. The aim of this study was to describe the “long‐ter...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6975934/ https://ncbi.nlm.nih.gov/pubmed/31164454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0786 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|